Search Results | Diabetes Care | American Diabetes Association

1-20 of 61

2 3 4

Sort by

Sort Order Select

Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023

Diabetes Care 2023;46(Supplement_1):S49–S67

DOI: https://doi.org/10.2337/dc23-S004

Published: 12 December 2022

View article

Journal Articles

Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251

Bo Liang, Ning Gu

Diabetes Care 2022;45(10):e150

DOI: https://doi.org/10.2337/dc22-0778

Published: 19 September 2022

View article

Journal Articles

Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251

Gaetano Santulli, Salvatore Frullone, Maria Morgante, Gaetano Macina, Antonella Pansini, Jessica Gambardella, Angela Lombardi, Pasquale Mone

Diabetes Care 2022;45(10):e151–e152

DOI: https://doi.org/10.2337/dci22-0025

Published: 19 September 2022

View article

Journal Articles

Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Pasquale Mone, Angela Lombardi, Jessica Gambardella, Antonella Pansini, Gaetano Macina, Maria Morgante, Salvatore Frullone, Gaetano Santulli

Diabetes Care 2022;45(5):1247–1251

DOI: https://doi.org/10.2337/dc21-2434

Published: 14 March 2022

View article

Journal Articles

Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study

Haiyan Cheng, Zhou Zhang, Bing Zhang, Wen Zhang, Jin Wang, Wenyu Ni, Yingwen Miao, Jiani Liu, Yan Bi

Diabetes Care 2022;45(5):1201–1210

DOI: https://doi.org/10.2337/dc21-2064

Published: 09 March 2022

View article

Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional Practice Committee

Diabetes Care 2022;45(Supplement_1):S46–S59

DOI: https://doi.org/10.2337/dc22-S004

Published: 16 December 2021

View article

Journal Articles

Response to Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701

Katherine Samaras, John D. Crawford, Brian Draper, Julian N. Trollor, Henry Brodaty, Perminder S. Sachdev

Diabetes Care 2021;44(4):e74

DOI: https://doi.org/10.2337/dci20-0077

Published: 15 March 2021

View article

Journal Articles

Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701

Jorge Rafael Violante-Cumpa, Luis Alberto Pérez-Arredondo, José Gerardo González-González, Leonardo Guadalupe Mancillas-Adame

Diabetes Care 2021;44(4):e73

DOI: https://doi.org/10.2337/dc20-2881

Published: 15 March 2021

View article

Journal Articles

Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes

Laili Soleimani, Ramit Ravona-Springer, Hung-Mo Lin, Xiaoyu Liu, Mary Sano, Anthony Heymann, Michal Schnaider Beeri

Diabetes Care 2021;44(3):655–662

DOI: https://doi.org/10.2337/dc20-2031

Published: 19 January 2021

View article

Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021

American Diabetes Association

Diabetes Care 2021;44(Supplement_1):S40–S52

DOI: https://doi.org/10.2337/dc21-S004

Published: 04 December 2020

View article

Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020

American Diabetes Association

Diabetes Care 2020;43(Supplement_1):S37–S47

DOI: https://doi.org/10.2337/dc20-S004

Published: 16 December 2019

View article

Journal Articles

Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial

Geert Jan Biessels, Chloë Verhagen, Jolien Janssen, Esther van den Berg, Bernard Zinman, Julio Rosenstock, Jyothis T. George, Anna Passera, Sven Schnaidt, Odd Erik Johansen

Diabetes Care 2019;42(10):1930–1938

DOI: https://doi.org/10.2337/dc19-0783

Published: 09 August 2019

View article

Includes: Supplementary data

Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019

American Diabetes Association

Diabetes Care 2019;42(Supplement_1):S34–S45

DOI: https://doi.org/10.2337/dc19-S004

Published: 07 December 2018

View article

Journal Articles

Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial

Tali Cukierman-Yaffe, Jackie Bosch, Hyejung Jung, Zubin Punthakee, Hertzel C. Gerstein

Diabetes Care 2019;42(1):142–147

DOI: https://doi.org/10.2337/dc18-0690

Published: 13 November 2018

View article

Includes: Supplementary data

Journal Articles

3. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2018

American Diabetes Association

Diabetes Care 2018;41(Supplement_1):S28–S37

DOI: https://doi.org/10.2337/dc18-S003

Published: 24 November 2017

View article

Journal Articles

Index

Diabetes Care 2018;41(Supplement_1):S156–S159

DOI: https://doi.org/10.2337/dc18-in01

Published: 24 November 2017

View article

Journal Articles

In This Issue of Diabetes Care

Diabetes Care 2017;40(11):1423–1424

DOI: https://doi.org/10.2337/dc17-ti11

Published: 12 October 2017

View article

Journal Articles

Comment on Ekblad et al. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758

Erfan Ayubi, Saeid Safiri

Diabetes Care 2017;40(9):e135

DOI: https://doi.org/10.2337/dc17-0876

Published: 14 August 2017

View article

Journal Articles

Response to Comment by Ayubi and Safiri. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758

Laura L. Ekblad, Juha O. Rinne, Pauli Puukka, Hanna Laine, Satu Ahtiluoto, Raimo Sulkava, Matti Viitanen, Antti Jula

Diabetes Care 2017;40(9):e136

DOI: https://doi.org/10.2337/dci17-0023

Published: 14 August 2017

View article

Journal Articles

Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline

Andreea M. Rawlings, A. Richey Sharrett, Thomas H. Mosley, Shoshana H. Ballew, Jennifer A. Deal, Elizabeth Selvin

Diabetes Care 2017;40(7):879–886

DOI: https://doi.org/10.2337/dc16-2203

Published: 13 June 2017

View article

Includes: Supplementary data

2 3 4

NARROW

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023

Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251

Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251

Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022

Response to Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701

Comment on Samara et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020;43:2691–2701

Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020

Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019

Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial

3. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2018

Index

In This Issue of Diabetes Care

Comment on Ekblad et al. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758

Response to Comment by Ayubi and Safiri. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care 2017;40:751–758

Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only